10:00 a.m. - 3:40 p.m. ET
Description
Research in the Treatment of Mitral Valve Prolapse 2024 will examine both the clinical and basic science of mitral valve prolapse (MVP), including diagnostic imaging, risk assessment, clinical management, surgical and transcatheter intervention, genetics, and disease mechanism. This 2024 workshop is an update of the 2021 workshop and part of the NHLBI’s implementation of the Cardiovascular Advances in Research and Opportunities Legacy (CAROL) Act.
Registration closes at 12 p.m. ET on December 11, 2024.
For programmatic questions, please email Frank Evans, Ph.D. at Frank.Evans@nih.gov and Jamie Gulin at Jamie.Gulin@nih.gov.
For logistical questions, please email the NHLBI Workshop Support Program Team (WSPT) at NHLBIWorkshopSupport@nih.gov.
Individuals requiring Sign Language Interpreters or other reasonable accommodations to facilitate their participation in this event should contact the WSPT: ATTN: Brittney Villafana at NHLBIWorkshopSupport@nih.gov at least five (5) days prior to the commencement of the workshop.